Results 1 to 10 of about 68,004 (228)
Dolutegravir use is related to lower HTLV-1 proviral load in people co-infected by HIV-1 [PDF]
Communications MedicineBackground Infection by human T-cell lymphotropic virus type 1 (HTLV-1) affects millions of people worldwide and causes severe diseases. To date, no specific treatment is available for HTLV infection. The purpose of this study was to determine the impact
Tatiana Fernandez +4 more
doaj +2 more sources
TAX and HBZ: hFc Ɣ 1 proteins as targets for passive immunotherapy [PDF]
Iranian Journal of Basic Medical Sciences, 2022 Objective(s): Human T leukemia virus type one (HTLV-1) causes two life-threatening diseases in around five percent of infected subjects, a T cell malignancy and a neurodegenerative disease.
Mohammad Akbarin +6 more
doaj +1 more source
Evaluating the Prevalence of Human T-cell Lymphotropic Virus in Blood Donors and Thalassemia and Hemophilia Patients in Rafsanjan and Jiroft Cities of Kerman Province, Iran [PDF]
Journal of Genetic Resources, 2023 Human T-cell leukemia virus (HTLV) is a member of the retroviridae family that can be transmitted through infected lymphocytes, sex, blood transfusion, and organ transplantation as well as from mother to child by breastfeeding.
Somayeh Mohajeri +9 more
doaj +1 more source
HTLV-1 Proviral Load in Vaginal Fluid Correlates with Levels in Peripheral Blood Mononuclear Cells
Pathogens, 2023 Background: The prevalence of human T-lymphotropic virus type-1 (HTLV-1) infection is higher in women, and sexual intercourse has been described as an important route of male-to-female transmission.
Alisson de Aquino Firmino +8 more
doaj +1 more source
Frontiers in Microbiology, 2012 Human T cell lymphotropic virus type 1 (HTLV-1) is the first retrovirus described as a causative agent of human disease. Following adult T cell leukemia/lymphoma and HLTV-1-associated myelopathy/tropical spastic paraparesis, HTLV-1 uveitis (HU) has been established as a distinct clinical entity caused by HTLV-1 based on seroepidemiological, clinical ...
Kamoi, Koju, Mochizuki, Manabu
openaire +3 more sources
Practical Neurology, 2021 A 53-year-old woman developed subacute onset of upper limb weakness, sensory loss and cerebellar dysfunction. She was known to have human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy. MR scan of the brain showed extensive T2 hyperintensity within the deep and subcortical white matter, with punctate contrast enhancement.
King-Robson, J +4 more
openaire +4 more sources
Prevalence of HBV, HDV and retrovirus infection in the matsés ethnic group in Loreto, Peru
Revista Peruana de Medicina Experimental y Salud Pública, 2020 Observational, cross-sectional, populational study to determine the prevalence of infection by hepatitis B virus (HBV), hepatitis D virus (HDV), human immunodeficiency virus (HIV) and human T-lymphotropic virus type 1 and 2 (HTLV-1/2) in the Matsés ...
César Cabezas +8 more
doaj +1 more source
Pathogens, 2021 The years 2020 and 2021 will remain memorable years for many reasons [...]
Journo, Chloé, Martin, Fabiola
openaire +4 more sources
Viruses, 2022 Human T-cell lymphotropic virus type 1 and 2 (HTLV-1/2) screening is not mandatory in Spanish blood banks. In Catalonia, selective screening was introduced in 2008, followed by universal screening in 2011.
Maria Piron +8 more
doaj +1 more source
Frontiers in Public Health, 2022 A multi-epitope protein expressed in a prokaryotic system, including epitopes of Env, Gag, and Tax proteins of both HTLV-1 and HTLV-2 was characterized for HTLV-1/2 serological screening.
Gabriela de Melo Franco +22 more
doaj +1 more source